Studies have shown that targeted silencing of DKC1 using RNAi (RNA interference) reduces gene expression in BC cell lines, resulting in decreased pseudouridilation in rRNAs and affecting the survival of proliferating cells (Montanaro et al., 2006; Elsharawy et al., 2020). The gene discussed is DKC1; the disease is breast cancer.